Literature DB >> 8816980

IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus.

S T Bennett1, A J Wilson, F Cucca, J Nerup, F Pociot, P A McKinney, A H Barnett, S C Bain, J A Todd.   

Abstract

IDDM2-encoded predisposition to type 1 diabetes has recently been mapped to the minisatellite or variable number of tandem repeat (VNTR) locus upstream of the insulin and insulin-like growth factor II genes on human chromosome 11p15.5. In a UK case-control study (n = 228 sporadic diabetics; n = 441 healthy controls), we show here that the genotype homozygous for VNTR class I alleles is predisposing to disease (RR = 2.68), and VNTR class III alleles are dominantly protective (RR = 0.37). In 722 diabetic families from the UK (n = 356), USA (n = 173), Denmark (n = 55) and Sardinia (n = 138), we have analysed the transmission of class I alleles to diabetic offspring from class I/III heterozygous parents. We confirm that in families from the USA, class I alleles are transmitted preferentially from fathers. However, in family data sets from the UK, Denmark and Sardinia, the reverse is true and maternal transmission is stronger. Furthermore, in the UK family data set, the difference between maternal and paternal transmissions is significant (P < 0.05). It is therefore unlikely that 'maternal imprinting' alone explains the parent-of-origin effects in IDDM2-encoded predisposition to type 1 diabetes, at least not in the UK. There is a relationship between VNTR class (allele length) and insulin gene expression, though some results from different studies are conflicting. In the human adult cadaveric pancreas, we confirm our preliminary results that class III alleles are associated with lower levels of insulin mRNA in vivo. Similar results have been obtained independently in human foetal pancreas samples. It is difficult to explain how these marginally lower levels of insulin expression could account for the observed VNTR class III-encoded protective effect. Perhaps the site of action of IDDM2, mediated by VNTR allelic variation, is not the pancreas but some other organ such as the thymus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816980     DOI: 10.1006/jaut.1996.0057

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  28 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

Authors:  Akane Ide; George S Eisenbarth
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

3.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

Review 4.  Regulatory polymorphisms underlying complex disease traits.

Authors:  Julian C Knight
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

Review 5.  Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.

Authors:  Rebecca Fuhlbrigge; Linda Yip
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 6.  Combination Immunotherapy for Type 1 Diabetes.

Authors:  Robert N Bone; Carmella Evans-Molina
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

7.  Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.

Authors:  Irene Jarchum; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

Review 8.  Genetics of autoimmune diabetes mellitus.

Authors:  Marie Cerná
Journal:  Wien Med Wochenschr       Date:  2008

9.  The insulin gene variable number of tandemrepeats (INS VNTR) genotype and sleep disordered breathing in childhood obesity.

Authors:  M Carotenuto; N Santoro; A Grandone; E Santoro; C Pascotto; A Pascotto; L Perrone; E Miraglia del Giudice
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

10.  Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.

Authors:  M Li; D-J Zheng; L L Field; V Bonnevie-Nielsen
Journal:  Exp Diabetes Res       Date:  2009-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.